Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.6120
+0.0371 (6.45%)
Jun 18, 2025, 4:00 PM - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $10.31 million as of June 18, 2025.
Market Cap
10.31M
Enterprise Value
6.70M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $10.31M, a decrease of -69.12%. That is a compound annual growth rate of -78.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 10.31M | -47.19% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |